Therapeutics

Barry Potter (Inventor), Andreas H Guse (Inventor), Georg W Mayr (Inventor), Katrin Schweitzer (Inventor)

Research output: Patent

Abstract

The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.
Original languageEnglish
Patent numberWO02098397 (A2)
IPCA61K31/7084
Publication statusPublished - 12 Dec 2002

Fingerprint

Ring
Salt

Cite this

Potter, B., Guse, A. H., Mayr, G. W., & Schweitzer , K. (2002). IPC No. A61K31/7084. Therapeutics. (Patent No. WO02098397 (A2)).

Therapeutics. / Potter, Barry (Inventor); Guse, Andreas H (Inventor); Mayr, Georg W (Inventor); Schweitzer , Katrin (Inventor).

IPC No.: A61K31/7084. Patent No.: WO02098397 (A2).

Research output: Patent

Potter, B, Guse, AH, Mayr, GW & Schweitzer , K 2002, Therapeutics, Patent No. WO02098397 (A2), IPC No. A61K31/7084.
Potter B, Guse AH, Mayr GW, Schweitzer K, inventors. Therapeutics. A61K31/7084. 2002 Dec 12.
Potter, Barry (Inventor) ; Guse, Andreas H (Inventor) ; Mayr, Georg W (Inventor) ; Schweitzer , Katrin (Inventor). / Therapeutics. IPC No.: A61K31/7084. Patent No.: WO02098397 (A2).
@misc{c54dca68d4334547b1f88ce6a1719e23,
title = "Therapeutics",
abstract = "The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.",
author = "Barry Potter and Guse, {Andreas H} and Mayr, {Georg W} and Katrin Schweitzer",
year = "2002",
month = "12",
day = "12",
language = "English",
type = "Patent",
note = "WO02098397 (A2); A61K31/7084",

}

TY - PAT

T1 - Therapeutics

AU - Potter, Barry

AU - Guse, Andreas H

AU - Mayr, Georg W

AU - Schweitzer , Katrin

PY - 2002/12/12

Y1 - 2002/12/12

N2 - The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.

AB - The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.

M3 - Patent

M1 - WO02098397 (A2)

ER -